Abstract
The pathophysiology of pulmonary hypertension (PH) in parenchymal lung diseases is partially related to hypoxic pulmonary vasoconstriction. PH treatment is controversial for these patients. This article focuses on group III PH, namely PH attributable to lung diseases and/or hypoxia. Group III includes chronic obstructive pulmonary disease and interstitial lung diseases, the most common parenchymal lung diseases associated with PH. It also includes sleep-disordered breathing and hypoventilation from any cause. Other parenchymal lung diseases associated with PH, namely sarcoidosis and systemic vasculitides (group V), are discussed. The data describing PH in specific parenchymal diseases are reviewed.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 461-474 |
| Number of pages | 14 |
| Journal | Heart Failure Clinics |
| Volume | 8 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jul 2012 |
Fingerprint
Keywords
- Chronic obstructive pulmonary disease
- Idiopathic pulmonary fibrosis
- Interstitial lung disease
- Pulmonary hypertension
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
Pulmonary Hypertension in Parenchymal Lung Disease. / Ruggiero, Rosechelle M.; Bartolome, Sonja; Torres, Fernando.
In: Heart Failure Clinics, Vol. 8, No. 3, 07.2012, p. 461-474.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Pulmonary Hypertension in Parenchymal Lung Disease
AU - Ruggiero, Rosechelle M.
AU - Bartolome, Sonja
AU - Torres, Fernando
PY - 2012/7
Y1 - 2012/7
N2 - The pathophysiology of pulmonary hypertension (PH) in parenchymal lung diseases is partially related to hypoxic pulmonary vasoconstriction. PH treatment is controversial for these patients. This article focuses on group III PH, namely PH attributable to lung diseases and/or hypoxia. Group III includes chronic obstructive pulmonary disease and interstitial lung diseases, the most common parenchymal lung diseases associated with PH. It also includes sleep-disordered breathing and hypoventilation from any cause. Other parenchymal lung diseases associated with PH, namely sarcoidosis and systemic vasculitides (group V), are discussed. The data describing PH in specific parenchymal diseases are reviewed.
AB - The pathophysiology of pulmonary hypertension (PH) in parenchymal lung diseases is partially related to hypoxic pulmonary vasoconstriction. PH treatment is controversial for these patients. This article focuses on group III PH, namely PH attributable to lung diseases and/or hypoxia. Group III includes chronic obstructive pulmonary disease and interstitial lung diseases, the most common parenchymal lung diseases associated with PH. It also includes sleep-disordered breathing and hypoventilation from any cause. Other parenchymal lung diseases associated with PH, namely sarcoidosis and systemic vasculitides (group V), are discussed. The data describing PH in specific parenchymal diseases are reviewed.
KW - Chronic obstructive pulmonary disease
KW - Idiopathic pulmonary fibrosis
KW - Interstitial lung disease
KW - Pulmonary hypertension
UR - http://www.scopus.com/inward/record.url?scp=84863088716&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84863088716&partnerID=8YFLogxK
U2 - 10.1016/j.hfc.2012.04.010
DO - 10.1016/j.hfc.2012.04.010
M3 - Article
C2 - 22748906
AN - SCOPUS:84863088716
VL - 8
SP - 461
EP - 474
JO - Heart Failure Clinics
JF - Heart Failure Clinics
SN - 1551-7136
IS - 3
ER -